Your browser doesn't support javascript.
loading
Multi-Shell Nanourchin-Integrated Dual Mode Lateral Flow Immunoassay for Sensitive and Rapid Detection of Clinical Cardiac Myosin-Binding Protein C.
Xu, Xuan; Yue, Shuzhen; Tu, Keke; Yuan, Baozhen; Bi, Sai; Yu, Jinjin; Qiu, Hui; Zhang, Haotian; Zhang, Lei; Wu, Heng-Fang; Chen, Xiang-Jian; Zhao, Sheng; Zhang, Wei; Zhang, Ji-Nan; Jiang, Li-Ping; Zhang, Jian-Rong; Zhu, Jun-Jie.
Afiliación
  • Xu X; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China.
  • Yue S; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China.
  • Tu K; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China.
  • Yuan B; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China.
  • Bi S; College of Chemistry and Chemical Engineering, Key Laboratory of Shandong Provincial Universities for Functional Molecules and Materials, Qingdao University, Qingdao 266071, P. R. China.
  • Yu J; Nanjing Bottests Biotech CO., LTD, Nanjing 211112, P. R. China.
  • Qiu H; Nanjing Bottests Biotech CO., LTD, Nanjing 211112, P. R. China.
  • Zhang H; Nanjing Bottests Biotech CO., LTD, Nanjing 211112, P. R. China.
  • Zhang L; Nanjing Bottests Biotech CO., LTD, Nanjing 211112, P. R. China.
  • Wu HF; Institute of Cardiovascular Disease, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, P. R. China.
  • Chen XJ; Institute of Cardiovascular Disease, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, P. R. China.
  • Zhao S; Institute of Cardiovascular Disease, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, P. R. China.
  • Zhang W; Institute of Cardiovascular Disease, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, P. R. China.
  • Zhang JN; Institute of Cardiovascular Disease, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, P. R. China.
  • Jiang LP; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China.
  • Zhang JR; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China.
  • Zhu JJ; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China.
Anal Chem ; 96(29): 11853-11861, 2024 Jul 23.
Article en En | MEDLINE | ID: mdl-38989993
ABSTRACT
Cardiac myosin-binding protein C (cMyBP-C) is a novel cardiac marker of acute myocardial infarction (AMI) and acute cardiac injuries (ACI). Construction of point-of-care testing techniques capable of sensing cMyBP-C with high sensitivity and precision is urgently needed. Herein, we synthesized an Au@NGQDs@Au/Ag multi-shell nanoUrchins (MSNUs), and then applied it in a colorimetric/SERS dual-mode immunoassay for detection of cMyBP-C. The MSNUs displayed superior stability, colorimetric brightness, and SERS enhancement ability with an enhanced factor of 5.4 × 109, which were beneficial to improve the detection capability of test strips. The developed MSNU-based test strips can achieve an ultrasensitive immunochromatographic assay of cMyBP-C in both colorimetric and SERS modes with the limits of detection as low as 19.3 and 0.77 pg/mL, respectively. Strikingly, this strip was successfully applied to analyze actual plasma samples with significantly better sensitivity, negative predictive value, and accuracy than commercially available gold test strips. Notably, this method possessed a wide range of application scenarios via combining with a color recognizer application named Color Grab on the smartphone, which can meet various needs of different users. Overall, our MSNU-based test strip as a mobile health monitoring tool shows excellent sensitivity, reproducibility, and rapid detection of the cMyBP-C, which holds great potential for the early clinic diagnosis of AMI and ACI.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Portadoras / Oro Límite: Humans Idioma: En Revista: Anal Chem Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Portadoras / Oro Límite: Humans Idioma: En Revista: Anal Chem Año: 2024 Tipo del documento: Article